Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Company News
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

ClinTec appoints ex-AstraZeneca executive as Global Head of Clinical Operations ClinTec appoints ex-AstraZeneca executive as Global Head of Clinical Operations Alastair MacDonald joins the firm with almost 25 years of experience in clinical development Chronos Therapeutics strengthens management team with two appointments Chronos Therapeutics strengthens management team with two appointments Dr Fraser Murray and Dr Timothy Schulz-Utermoehl join the firm as Vice Presidents of Pre-Clinical Development Halocarbon hires H. Carl Walther as technical services manager Halocarbon hires H. Carl Walther as technical services manager 31-year veteran spent 18 years with Krytox performance lubricants PCI Pharma Services welcomes two new Business Development Executives PCI Pharma Services welcomes two new Business Development Executives To develop the outsourcing services provider's growing US business Parexel adds four executives to senior leadership team Parexel adds four executives to senior leadership team All have been with the firm for a number of years Cornelius makes a promotion Cornelius makes a promotion Darren Spiby moves up from Managing Director to Chief Executive Officer John C. Lechleiter to retire as CEO of Lilly John C. Lechleiter to retire as CEO of Lilly David A. Ricks will assume President and CEO roles on 1 January 2017 VBI Vaccines appoints Dr Francisco Diaz-Mitoma as Chief Medical Officer VBI Vaccines appoints Dr Francisco Diaz-Mitoma as Chief Medical Officer He will oversee clinical development initiatives at the firm ContraFect names Steven Gilman as Chief Executive Officer ContraFect names Steven Gilman as Chief Executive Officer The US firm is a developer of protein and anti-body therapeutics Ethiopia receives 14 million praziquantel tablets from Merck Ethiopia receives 14 million praziquantel tablets from Merck Will be used to treat the 23% of Ethiopians who are suffering from the worm disease schistosomiasis Certara appoints Nathan Teuscher to lead Phoenix software division Certara appoints Nathan Teuscher to lead Phoenix software division Phoenix is used to analyse the safety and efficacy of drugs under development PSL goes to Buckingham Palace to receive its Queen's Awards for Enterprise PSL goes to Buckingham Palace to receive its Queen's Awards for Enterprise The manufacturer of filter dryers, glove box and isolator containment systems for the pharmaceutical and biopharmaceutical industries was recognised for both Innovation and... Peakdale adds two new team members to extend its biological offering Peakdale adds two new team members to extend its biological offering Christopher Doe and Sascha Hartmann join the UK firm Adents hires Chuck Sailer as Serialisation Solutions Expert Adents hires Chuck Sailer as Serialisation Solutions Expert Sailer will apply his skills to Adents Pharma Suite, which uses standardised turnkey unit-level serialisation software Former Sandoz CEO joins supervisory board of Leukocare Former Sandoz CEO joins supervisory board of Leukocare Dr Andreas Rummelt, pharma industry expert and former CEO of Sandoz, was elected as a new supervisory board member at Leukocare's annual shareholder meeting on 12 July Tekni-Plex names executives for its Tekni Films and Tri-Seal closure liners business units Tekni-Plex names executives for its Tekni Films and Tri-Seal closure liners business units Global packaging, medical compounds and tubing supplier promotes from within Regeneron names 2016 winners of the Regeneron Prize for Creative Innovation Regeneron names 2016 winners of the Regeneron Prize for Creative Innovation The award was established to acknowledge, reward and foster talented early-career biomedical scientists David Meek to join Ipsen as Chief Executive David Meek to join Ipsen as Chief Executive He has held various global executive positions in major pharma and biotech firms in a career spanning more than 25 years Japanese scientist Dr Tasuku Honjo shares 2016 Kyoto Prize Japanese scientist Dr Tasuku Honjo shares 2016 Kyoto Prize He discovered the mechanism responsible for the functional diversification of antibodies, immunoregulatory molecules and clinical applications of PD-1 CXR Biosciences appoints Professor Brian Lake as an Associate Toxicologist CXR Biosciences appoints Professor Brian Lake as an Associate Toxicologist Strengthening the firm's mechanistic toxicology and industry expertise Zenith Technologies appoints Serialisation Director Zenith Technologies appoints Serialisation Director Carlos Machado will lead the firm's sales, operations, implementation and post project support services in the US Recipharm appoints new General Manager at Research Triangle Park, US Recipharm appoints new General Manager at Research Triangle Park, US Ann Flodin moves up to the position from a senior position in Group Operations Development DBV Technologies welcomes Dr Lucia Septien as Chief Medical Officer DBV Technologies welcomes Dr Lucia Septien as Chief Medical Officer Septien was most recently Vice President, Global Neurosciences at Ipsen Herma launches US subsidiary and appoints Peter Goff as CEO Herma launches US subsidiary and appoints Peter Goff as CEO Goff, formerly Director of Sales for the firm's UK subsidiary, has been with Herma for more than 25 years
  • Previous
  • 1
  • …
  • 58
  • 59
  • 60
  • 61 (current)
  • 62
  • 63
  • 64
  • …
  • 140
  • Next

Trending Articles

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.